Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.055 | 0.7 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.8 |